[144] Core Molding Technologies, Inc. SEC Filing

Rhea-AI Filing Summary

Core Molding Technologies, Inc. (CMT) filing a Form 144 notifies a proposed sale of 6,020 common shares on 09/08/2025 through Charles Schwab (3000 Schwab Way, Westlake, TX) on the NYSE AMEX with an aggregate market value listed as $119,410. The filing reports the shares were acquired through vested stock grants issued by the company: 2,780 shares on 06/15/2022, 1,732 shares on 03/10/2023 and 1,508 shares on 03/07/2024. The filer certifies no undisclosed material adverse information and confirms there were no sales in the past three months by the selling person.

Positive

• Full disclosure of broker, share count, market value, and acquisition history complies with Rule 144 requirements
• Securities originate from vested stock grants, indicating the sale arises from equity compensation rather than third-party transfer

Negative

• Insider sale is planned, representing a liquidity event by a person associated with the issuer

Insights

Securities Analyst

TL;DR: Routine insider sale notice from vested equity; modest size relative to outstanding shares.

The Form 144 documents a planned sale of 6,020 common shares acquired via equity compensation on three vesting dates. The filing provides clear broker and execution date details and affirms no undisclosed material adverse information. From a trading-impact perspective, the transaction appears administrative: the shares originate from vested grants rather than a secondary transfer or large block sale. There is no evidence in this filing of unusual timing or repeat sales in the prior three months, as the filer reports nothing to report for that period.

Corporate Governance Specialist

TL;DR: Compliance-oriented disclosure of an insider sale; supports transparency but shows insider liquidity event.

The document satisfies Rule 144 disclosure requirements by listing the security class, broker, quantity, market value, and acquisition history. The shares were obtained through vested stock grants, which is a common source for insider sales. The signature/representation language is included, attesting the filer is not aware of undisclosed material adverse facts. For governance monitoring, this is a routine disclosure that facilitates market transparency without indicating a governance concern on its face.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab Corp. 3000 Schwab Way Westlake TX 76262	6020	119410.00	8857907	09/08/2025	NYSE AMEX

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Comon	06/15/2022	Vested Stock Grants	Issuer			2780	06/15/2022	Equity Compensation
Common	03/10/2023	Vested Stock Grants	Issuer			1732	03/10/2023	Equity Compensation
Common	03/07/2024	Vested Stock Grants	Issuer			1508	03/07/2024	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is being reported in the CMT Form 144 filing?

The filing reports a proposed sale of 6,020 common shares of Core Molding Technologies (CMT) to be executed on 09/08/2025 on the NYSE AMEX through Charles Schwab, with aggregate value listed as $119,410.

Where did the shares proposed for sale come from according to the filing?

The shares were acquired via vested stock grants: 2,780 shares on 06/15/2022, 1,732 shares on 03/10/2023, and 1,508 shares on 03/07/2024.

Did the filer report any sales of issuer securities in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

Which broker and exchange are listed for the proposed sale?

The broker listed is Charles Schwab Corp. (3000 Schwab Way, Westlake, TX) and the exchange noted is NYSE AMEX.

Does the filing indicate any undisclosed material adverse information about CMT?

By signing the notice, the person represents they do not know of any material adverse information regarding the issuer that has not been publicly disclosed.